Sundar PichaiSundar Pichai earned $164M in 2023

Christopher Ryan, Ph.D., is the current President, Chief Operating Officer, and Chief Technology Officer of Gevo, Inc. Since joining in 2009, he has been pivotal in advancing the company’s mission to produce renewable fuels and chemicals from biobased materials. Dr....

Quick Links
G

Christopher Ryan, Ph.D.

CEO of Gevo

Sector of Economy

Basic Materials

CEO of Gevo for

12 years 7 months (Sep 2012 - Present)

Previous Experience

Unknown

Rivals

Competitors/colleagues of Christopher Ryan, Ph.D.

Holdings

See how much did Christopher Ryan, Ph.D. make over time.

Dr. Ryan has consistently been an active participant in buying and selling shares of Gevo, illustrating his belief in the company's potential. Notably, he traded sizable amounts in 2021, reaching peaks with sales exceeding $7 million in a single month....

Total Stock Sold

$1.24B

GEVO

$1.24B

498,668 GEVO shares

What if they kept their stock?

If Christopher Ryan, Ph.D. didn't sell their stock, today they would have:
Extra GEVO498,668 shares worth $528.59K.
This is -99.96% and $1.23B less than what they got when they sold the stock.

Insider Trading

See recent insider trades of Christopher Ryan, Ph.D..

GEVO

10,000 shares

GEVO

Sep 1, 2024

Received

GEVO

$63.63K

GEVO at $0.76/share

Aug 22, 2024

Sale

GEVO

$23.58K

GEVO at $0.51/share

Aug 6, 2024

Sale

GEVO

$23.48K

GEVO at $0.59/share

Jul 31, 2024

Sale

GEVO

550,000 shares

GEVO

May 22, 2024

Received

GEVO

$115.62K

GEVO at $1.38/share

Aug 23, 2023

Sale

GEVO

266,220 shares

GEVO

Aug 3, 2023

Received

GEVO

$60.27K

GEVO at $1.65/share

Jul 28, 2023

Sale

GEVO

$207.85K

GEVO at $3.08/share

Aug 22, 2022

Sale

GEVO

234,711 shares

GEVO

Jul 26, 2022

Received

Compensation History

See how much did Christopher Ryan, Ph.D. make over time.

In 2023, Dr. Ryan's total compensation was $844,605, comprising a salary of $421,512 and performance-related bonus of $423,093, which included efforts linked to Gevo's Net-Zero 1 project. This bonus system is designed to align his interests with the company’s goals. In previous years, his compensation saw fluctuations, reaching over $1.4 million in 2022, largely due to stock vesting and bonuses based on performance metrics. The compensation package aims to retain top talent while ensuring executive pay correlates closely with company performance. This structure shows that for Dr. Ryan, success at Gevo means more than just words—it's about tangible results.

Year

2023

Total Compensation

$1.23M

Salary

$421.51K

Board Justification

The compensation philosophy focuses on aligning executive compensation with company performance and long-term shareholder value, using a mix of cash and equity incentives to attract and retain top talent.

Bonus

$423.09K

Board Justification

The bonus is based on the achievement of certain business goals set by the Board on an annual basis, including a Special Net-Zero 1 Bonus for significant progress made towards achieving financial close for the Net-Zero 1 project.

Other

$0.00

Board Justification

No additional compensation reported for 2023.

Restricted Stock

$381.83K(252.54K RSU)

Board Justification

The stock awards that vested in 2023 were granted in prior years and are based on the achievement of performance metrics and continued service with the company.

Performance Metrics

The performance metrics include achieving specific business goals set by the Board, which are tied to the company's operational and financial objectives.